MAM

Monaco Asset Management Portfolio holdings

AUM $337M
1-Year Est. Return 32.01%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+32.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$269M
AUM Growth
+$4.59M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1 +$14.5M
2 +$13.8M
3 +$7.68M
4
MRVI icon
Maravai LifeSciences
MRVI
+$7.09M
5
ACLX icon
Arcellx
ACLX
+$5.66M

Sector Composition

1 Healthcare 38.55%
2 Materials 18.62%
3 Energy 16.64%
4 Consumer Discretionary 12.41%
5 Communication Services 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRQR icon
51
ProQR Therapeutics
PRQR
$167M
$980K 0.36%
460,000
FATE icon
52
Fate Therapeutics
FATE
$171M
$970K 0.36%
770,000
+95,000
TEO icon
53
Telecom Argentina
TEO
$5.03B
$872K 0.32%
+120,000
OFIX icon
54
Orthofix Medical
OFIX
$536M
$850K 0.32%
58,059
+1,690
PSKY
55
Paramount Skydance Corp
PSKY
$14.9B
$804K 0.3%
+42,500
FET icon
56
Forum Energy Technologies
FET
$660M
$801K 0.3%
30,000
-20,000
ALCO icon
57
Alico
ALCO
$316M
$763K 0.28%
22,005
GT icon
58
Goodyear
GT
$2.36B
$748K 0.28%
100,000
+30,000
RUM icon
59
Rumble
RUM
$1.83B
$724K 0.27%
+100,000
VTYX icon
60
Ventyx Biosciences
VTYX
$1B
$702K 0.26%
225,603
-536,288
PRTA icon
61
Prothena Corp
PRTA
$467M
$683K 0.25%
70,000
QTTB icon
62
Q32 Bio
QTTB
$56.1M
$616K 0.23%
311,137
-280,800
TVRD
63
Tvardi Therapeutics
TVRD
$37.4M
$530K 0.2%
+13,590
ALGN icon
64
Align Technology
ALGN
$13.6B
$501K 0.19%
+4,000
YPF icon
65
YPF
YPF
$13.9B
$486K 0.18%
+20,000
CC icon
66
Chemours
CC
$2.73B
$475K 0.18%
+30,000
LXRX icon
67
Lexicon Pharmaceuticals
LXRX
$614M
$473K 0.18%
350,000
-181,600
RTAC
68
Renatus Tactical Acquisition Corp I
RTAC
$325M
$443K 0.16%
40,592
-5,000
GGAL icon
69
Galicia Financial Group
GGAL
$7.2B
$413K 0.15%
+15,000
TDW icon
70
Tidewater
TDW
$3.94B
$292K 0.11%
+5,469
CYPH
71
Cypherpunk Technologies Inc
CYPH
$35.4M
-1,050,000
LYB icon
72
LyondellBasell Industries
LYB
$18.5B
-10,000
ABBV icon
73
AbbVie
ABBV
$410B
0
ORIC icon
74
Oric Pharmaceuticals
ORIC
$1.31B
-20,000
V icon
75
Visa
V
$616B
0